MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENTMaterial Transfer, Option and Research License Agreement • May 5th, 2020 • New York
This Material Transfer, Option and Research License Agreement (the “Agreement”) dated as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Lightlake Therapeutics, Inc. (“Lightlake”), having a place of business at 96-98 Baker Street, First Floor, London, UK, W1U 6TJ.
AMENDED AND RESTATED MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENT between OPIANT PHARMACEUTICALS, INC. and AEGIS THERAPEUTICS, LLCMaterial Transfer, Option and Research License Agreement • June 8th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • New York
This Amended and Restated Material Transfer, Option and Research License Agreement (the “Agreement”) as executed on April 26, 2016 and effective as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Opiant Pharmaceuticals, Inc. (f/k/a Lightlake Therapeutics Inc.) (“Opiant”), having a place of business at 401 Wilshire Blvd., 12th Floor, Santa Monica, CA 90401.
MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENTMaterial Transfer, Option and Research License Agreement • March 17th, 2015 • Lightlake Therapeutics Inc. • Metal mining • New York
This Material Transfer, Option and Research License Agreement (the “Agreement”) dated as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Lightlake Therapeutics, Inc. (“Lightlake”), having a place of business at 96-98 Baker Street, First Floor, London, UK, W1U 6TJ.
AMENDMENT NO. 2 TO THE MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENT EFFECTIVE AS OF DECEMBER 1, 2014Material Transfer, Option and Research License Agreement • October 26th, 2015 • Lightlake Therapeutics Inc. • Metal mining
WHEREAS, Aegis Therapeutics, LLC, (“Aegis”) and Lightlake Therapeutics Inc. (“Lightlake”) have previously entered into the Material Transfer, Option and Research License Agreement dated as of December 1, 2014, as amended on December 16, 2014 (the “Agreement”); and
MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENTMaterial Transfer, Option and Research License Agreement • June 12th, 2015 • Lightlake Therapeutics Inc. • Metal mining • New York
This Material Transfer, Option and Research License Agreement (the “Agreement”) dated as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Lightlake Therapeutics, Inc. (“Lightlake”), having a place of business at 96-98 Baker Street, First Floor, London, UK, W1U 6TJ.
